Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment

GOCMEN A. Y., SAHIN E., Kocak H., Tuncer M., GÜMÜŞLÜ S.

CLINICAL BIOCHEMISTRY, cilt.41, sa.10-11, ss.836-840, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 10-11
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.clinbiochem.2008.04.006
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.836-840
  • Anahtar Kelimeler: end-stage renal disease (ESRD), continuous ambulatory peritoneal dialysis (CAPD), asymmetric dimethylarginine (ADMA), nitric oxide synthase, nitric oxide, oxidative stress, paraoxonase, oxidized low-density lipoprotein, 4-hydroxynonenal, ceruloplasmin, CORONARY-ARTERY-DISEASE, PLASMA-CONCENTRATIONS, OXIDATIVE STRESS, ANTALYA REGION, LIPOPROTEIN, FAILURE, MALONDIALDEHYDE, INHIBITOR, INDEXES, SERUM
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives: In this study, we aimed to investigate the activities of paraoxonase-1 (PON1) and nitric oxide synthase (NOS) and the levels of asymmetric dimethylarginine (ADMA), nitric oxide (NO), oxidized low-density lipoprotein (oxLDL), ceruloplasmin (CP), thiobarbituric acid-reactive substances (TBARS), malondialdehyde (MDA), 4-hydroxynonenal (HNE) and lipids in serum of patients with end-stage renal disease (ESRD) having continuous ambulatory peritoneal dialysis (CAPD) treatment and controls living in the Antalya region, Turkey.